Research across SARS-CoV-2 infection
Related studies from across the SARS-CoV-2 infection family.
One in six blood donors in Cameroon carries Plasmodium infection, meta-analysis finds
1 in 6 blood donors in Cameroon carries malaria parasite
A systematic review and meta-analysis of 18 studies (~12,500 donations) found a 16.6% pooled prevalence of Plasmodium spp. in Cameroonian bl…
A review of 18 studies finds 16.6% of blood donations in Cameroon contain Plasmodium, the malaria parasite.
Two doses of SARS-CoV-2 vaccine show protective effect against MIS-C in children
Two vaccine doses linked to lower MIS-C risk in children
A systematic review finds two vaccine doses significantly lower MIS-C risk in children with SARS-CoV-2 infection, while one dose shows a non…
A review of studies finds two doses of a SARS-CoV-2 vaccine are linked to a lower risk of MIS-C in children who get infected.
Systematic review compares viral and bacterial pathogen mechanisms in respiratory infections
Understanding how different germs hurt lungs helps doctors treat patients better and faster today
This systematic review synthesizes evidence regarding receptor recognition, cellular injury, and immunopathological mechanisms across SARS-C…
This review explains how three common germs damage human cells in unique ways. Knowing these differences helps doctors predict sickness and …
Review of antibody-based strategies against RSV and SARS-CoV-2 in infants
New antibody treatments for babies lower virus hospitalization risk greatly
This narrative review examines antibody-based strategies against respiratory syncytial virus and SARS-CoV-2 in infants. It reports that nirs…
A review of antibody treatments for babies shows they greatly lower hospitalization risk from respiratory viruses. These medicines stay effe…
Clozapine Use Linked to Higher SARS-CoV-2 Infection Risk in Severe Mental Disorders
Clozapine users faced higher risk of severe COVID-19 in large study
A meta-analysis of 155,945 outpatients with severe mental disorders found that clozapine users had a higher rate of SARS-CoV-2 infection com…
A massive analysis of over 155,000 people found that those taking clozapine had higher rates of infection and worse outcomes from COVID-19.
Preclinical study characterizes SARS-CoV-2 particles in infected cells and patient nasal swabs using flow virometry
Lab study finds new way to detect SARS-CoV-2 particles in patient samples
This preclinical research article describes the detection and characterization of single SARS-CoV-2 viral particles.
A lab study shows a method can detect SARS-CoV-2 particles directly in patient nasal swabs without extra preparation steps.
Narrative review suggests time-related biases may attenuate apparent vaccine survival benefits in cancer patients
New math shows vaccine benefits in cancer care might be overstated
This narrative review and target trial emulation examines 3-year overall survival in cancer patients receiving COVID-19 vaccines versus thos…
A new look at the data reveals that timing errors made the vaccine look more powerful than it actually is for cancer patients.
Metformin, fluvoxamine, or ivermectin for non-hospitalized COVID-19 adults in a Phase 3 trial
Metformin Cuts Long Covid Risk by 40%
This randomized controlled trial in 1323 non-hospitalized adults with SARS-CoV-2 infection evaluated metformin, fluvoxamine, or ivermectin v…
A common diabetes pill taken early in Covid infection cuts the odds of developing long-term symptoms by 40%, offering new hope for millions.
Algorithm development study validates FindPart-w model for identifying SARS-CoV-2 lineage groups in the US
New tool sorts virus variants by how fast they spread
This algorithm development and validation study evaluates the FindPart-w algorithm and constrained RelRe model against the Pango lineage nom…
A new math tool groups virus variants by how fast they spread instead of just looking at their genetic makeup alone.
Nirmatrelvir-ritonavir showed no reduction in hospitalization or death within 28 days for higher-risk adults in community trials
New Study Questions Early Use of Paxlovid for Vaccinated Patients
In community-based trials involving higher-risk adults with recent SARS-CoV-2 infection, adding nirmatrelvir-ritonavir to usual care did not…
Getting vaccinated changes how your body fights the virus, and this new research shows that taking Paxlovid early might not be necessary for…
Infection status associated with hypoxemia and death rates varying by virus type in a large US cohort
Triple Virus Infections Rarer Than Feared — Here’s the Real Risk
This cohort study of 835,987 triple-tested patients in the US Veterans Health Administration examined associations between infection status …
It’s winter. Your throat is scratchy. Your chest feels tight.
Narrative review outlines VLP engineering strategies for broadly protective vaccines against multiple viral pathogens
New Vaccine Map Helps Pick Best Tools
This narrative review examines virus-like particle (VLP) engineering strategies, including genetic fusion, modular conjugation, and nucleic …
Imagine trying to fix a leaky roof with every tool in the shed.